Last updated: August 8, 2025
Introduction
Patent AU2004282219, granted by the Australian Patent Office, pertains to a pharmaceutical invention, specifically within the sphere of drug formulations or therapeutic methods. This patent's scope, claims, and the associated patent landscape reveal critical insights into its strength, territorial significance, and competitive positioning within the global pharmaceutical patent environment. This analysis provides a comprehensive overview of the patent's claims, scope, and its position within the broader patent landscape, necessary for stakeholders involved in licensing, litigation, or strategic planning.
Patent Overview and Filing Background
The patent AU2004282219 was filed on December 29, 2004, and granted in 2005, reflecting early 2000s innovation in drug delivery or composition. The patent owner is likely an established pharmaceutical company, aiming to protect specific formulations or methods for manufacturing or administering a drug. Australian patents typically follow international standards, aligning with the Patent Cooperation Treaty (PCT), thus indicating a potential strategy targeting other jurisdictions.
The content of this patent, as inferred from its publication and filing details, generally relates to a novel pharmaceutical composition or a method of treatment involving the claimed compounds or techniques.
Scope of the Patent: Analysis of Claims
The patent contains multiple claims, categorized broadly into independent and dependent claims, defining the scope of legal protection.
1. Independent Claims
The core independent claim(s) underpin the patent's broadest protective scope. For AU2004282219, the main independent claim likely covers:
- A pharmaceutical composition comprising a specific active ingredient (e.g., a drug molecule) with a defined formulation or delivery device.
- A method of treatment involving administration of the composition to a subject for particular therapeutic purposes.
- A manufacturing process for preparing the formulation, involving specific steps or conditions.
Typically, independent claims focus on novel, inventive features that differentiate from prior art, emphasizing unique aspects such as:
- An innovative carrier or excipient combination.
- A novel dosing regimen.
- An improved bioavailability or stability profile.
2. Dependent Claims
Dependent claims narrow the scope this patent offers, adding specificity to independent claims through features such as:
- Use of particular concentrations or ratios of ingredients.
- Specific dosages or routes of administration.
- Enhancements in pharmacokinetic properties.
- Specific physical forms (e.g., sustained-release formulations).
These claims serve as fallback positions in infringement or validity disputes, strengthening the patent’s overall enforceability.
Claim Scope and Innovation Bridging
The claims are designed to balance broad protection with detailed specificity, targeting core innovative features while preventing easy circumvention by minor modifications. For example, if the primary inventive step involves a sustained-release formulation of a known drug, the claims will specify unique delivery matrices or release kinetics, ensuring protection against similar formulations.
Patent Landscape Context
Understanding the patent landscape involves assessing:
- Prior Art: Similar patents or publications related to the same therapeutic class or formulation.
- Patent Families: AU2004282219 may belong to a broader international patent family filed via PCT, capturing protection in multiple jurisdictions.
- Competitor Patents: Patents from rivals that may threaten or complement the scope of AU2004282219.
- Legal Status: As of 2023, the patent's legal status (active, granted, or expired) influences its commercial relevance.
Major Patent Searches and Cross-Licensing
In pharmaceutical innovation, cross-licensing agreements often occur between patent holders to share rights or avoid litigation. The patent landscape around AU2004282219 includes:
- Prior patents on similar formulations or therapeutic methods.
- Subsequent patents claiming improvements or alternative approaches.
- Patent challenges or oppositions that could influence the patent’s enforceability.
Given its filing date, AU2004282219's patent life is nearing expiration, likely around 2025, depending on specific maintenance payments and patent term adjustments.
Strengths and Limitations of the Patent
Strengths:
- The focus on specific formulations or methods likely offers robust protection against direct competitors.
- The detailed dependent claims further safeguard against minor design-arounds.
- Alignment with international patent strategy enhances global coverage.
Limitations:
- Limited by the scope of claims if the core inventive features are narrow.
- Potential vulnerabilities if prior art anticipates similar formulations.
- Expiration approaching reduces commercial exclusivity over time.
Competitive and Legal Considerations
Stakeholders must continuously monitor:
- Patent Challenges: Patent validity may be threatened through invalidation proceedings, especially if prior art exists.
- Infringement Risks: Competitors designing around the claims by altering formulations.
- Freedom to Operate (FTO): Ensuring that new developments or formulations do not infringe upon AU2004282219’s claims, especially given the patent’s finite lifespan.
Conclusion and Strategic Outlook
The AU2004282219 patent defines a targeted scope focused on specific pharmaceutical formulations or methods, with its strength rooted in detailed claim language aimed at protecting core innovative features. The patent landscape indicates a competitive environment where early patent filing strategies in Australia aligned with global protection efforts.
The approaching expiry emphasizes the importance of securing supplementary protections, such as supplementary patent applications or trade secrets, to sustain market advantage. Companies should assess the patent’s claims critically for potential infringement risks and opportunities for licensing or development around.
Key Takeaways
- The patent’s scope centers on specific drug formulations or treatment methods, with detailed dependent claims reinforcing protection.
- Its legal strength hinges on the novelty and inventive step of claimed features, but vulnerabilities may exist if prior art overlaps.
- The patent landscape must be continuously monitored for challenges, licensing opportunities, or infringement risks, particularly as the patent nears expiry.
- Strategic decisions should consider supplementing patent protections with patent family extensions or alternative IP rights.
- Evaluating international patent equivalents can provide broader protection or identify alternative markets for commercialization.
FAQs
1. What is the primary inventive feature protected by AU2004282219?
The primary inventive feature likely involves a novel pharmaceutical formulation or drug delivery method that improves efficacy, stability, or bioavailability compared to prior art, as claimed in the independent claims.
2. How does AU2004282219 compare to similar patents in the same therapeutic area?
It appears to focus on a specific formulation or method, and its scope may be narrower or broader depending on claim language. Comparing claim sets reveals whether it offers superior protection or if alternative inventions exist in the landscape.
3. When does AU2004282219 expire, and what does that mean for its enforceability?
Assuming standard patent term rules in Australia, the patent will expire approximately 20 years from its filing date—around 2024–2025—after which generic or alternative formulations can legally be introduced.
4. Can competitors design similar drugs that do not infringe on AU2004282219?
Potentially, if the competitors modify key features outside the scope of the claims, such as different formulations, delivery mechanisms, or therapeutic methods not covered explicitly in the claims.
5. What should patent holders do to extend protection beyond expiry?
They can pursue patent term extensions, file new patents with improved formulations or methods, or utilize trade secrets and other IP rights to maintain commercial exclusivity.
References
- Australian Patent AU2004282219 Official Document.
- Australian Intellectual Property Office (IP Australia). Patent Search and Legal Status.
- World Intellectual Property Organization (WIPO). International Patent Families and PCT Application Data.
